TY - JOUR
T1 - Development and validation of a short portable sarcopenia measure in the African American health project
AU - Miller, Douglas K.
AU - Malmstrom, Theodore K.
AU - Andresen, Elena M.
AU - Miller, J. Philip
AU - Herning, Margaret M.
AU - Schootman, Mario
AU - Wolinsky, Fredric D.
N1 - Funding Information:
This study was supported by a grant from the National Institute on Aging to D.K.M. (R01 AG-10436). This article was presented in part in abstract form at the 2002 Annual Scientific Meeting of the Gerontological Society of American, Boston, November 5, 2002, and at the 2006 Annual Scientific Meeting of the American Geriatrics Society, Chicago, May 5, 2006. Dr F.D.W is Associate Director of the Center for Research in the Implementation of Innovative Strategies in Practice at the Iowa City VA Medical Center and funded through the Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development Service.
PY - 2009/3
Y1 - 2009/3
N2 - Background. Poor muscle size and function (sarcopenia) have an important role in the age-associated disability process. However, no commonly accepted index of sarcopenia exists for use in epidemiological studies. Methods. A cohort of 998 community-dwelling African Americans 49-65 years' old at baseline was used to construct the short portable sarcopenia measure (SPSM). SPSM was conceptualized as a measure of sarcopenia that combines estimates of muscle quantity and function into a single scale, is based on component items that can be obtained easily in the field, represents muscle status at a single time point that can be used without sex-specific adjustments, and can be used to follow change in muscle status over time with each person as his or her own control. We used exploratory factor analysis (EFA) to identify a unidimensional scale based on timed chair rises, lean mass, and grip strength divided by height. We used these three items and their EFA factor weights to construct SPSM (mean 9.0, median 9, range 0 [worst] to 18 [best] at baseline). Construct validity of the new measure, over a period of 36 months was examined. Results. SPSM required 8.5 pounds of equipment and 12.4 minutes to complete. It showed good score distribution and convergent, discriminant, and predictive validity with measures of muscle function, body composition, physical performance, psychological factors, and functional limitation cross-sectionally and with muscle function and body composition longitudinally. Extensive sensitivity analyses confirmed SPSM's robustness. Conclusions. SPSM is a brief, portable, and valid measure of sarcopenia for use in epidemiological research. Similar studies in other populations are needed.
AB - Background. Poor muscle size and function (sarcopenia) have an important role in the age-associated disability process. However, no commonly accepted index of sarcopenia exists for use in epidemiological studies. Methods. A cohort of 998 community-dwelling African Americans 49-65 years' old at baseline was used to construct the short portable sarcopenia measure (SPSM). SPSM was conceptualized as a measure of sarcopenia that combines estimates of muscle quantity and function into a single scale, is based on component items that can be obtained easily in the field, represents muscle status at a single time point that can be used without sex-specific adjustments, and can be used to follow change in muscle status over time with each person as his or her own control. We used exploratory factor analysis (EFA) to identify a unidimensional scale based on timed chair rises, lean mass, and grip strength divided by height. We used these three items and their EFA factor weights to construct SPSM (mean 9.0, median 9, range 0 [worst] to 18 [best] at baseline). Construct validity of the new measure, over a period of 36 months was examined. Results. SPSM required 8.5 pounds of equipment and 12.4 minutes to complete. It showed good score distribution and convergent, discriminant, and predictive validity with measures of muscle function, body composition, physical performance, psychological factors, and functional limitation cross-sectionally and with muscle function and body composition longitudinally. Extensive sensitivity analyses confirmed SPSM's robustness. Conclusions. SPSM is a brief, portable, and valid measure of sarcopenia for use in epidemiological research. Similar studies in other populations are needed.
KW - African Americans
KW - Aging
KW - Disability
KW - Muscles
UR - http://www.scopus.com/inward/record.url?scp=64849095747&partnerID=8YFLogxK
U2 - 10.1093/gerona/gln033
DO - 10.1093/gerona/gln033
M3 - Article
C2 - 19181712
AN - SCOPUS:64849095747
SN - 1079-5006
VL - 64
SP - 388
EP - 394
JO - Journals of Gerontology - Series A Biological Sciences and Medical Sciences
JF - Journals of Gerontology - Series A Biological Sciences and Medical Sciences
IS - 3
ER -